Perrigo rejects Mylan, opening door for Teva
April 21, 2015 at 17:14 PM EDT
Irish drug maker Perrigo turns down Mylan takeover bid of $205 a share, giving Teva Pharmaceuticals Industries an opportunity to pursue Mylan.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.